Comprehensive gene expression patterns generated from cDNA microarrays were correlated
with detailed clinico-pathological characteristics and clinical outcome in an unselected …

Background: Germline mutations in BRCA1 and BRCA2 are responsible for 5%–10% of
epithelial ovarian cancers, but the molecular pathways affected by these mutations are unknown…

… Amir A. Jazaeri declares that he has received research funding from AstraZeneca, Iovance
Biotherapeutics, Pfizer, and Bristol-Myers Squibb. He has served on Advisory Boards for …

Purpose: The goal of this study was to determine whether distinct gene expression profiles
are associated with intrinsic and/or acquired chemoresistance in epithelial ovarian carcinoma…

2538 Background: There is a high unmet medical need for effective treatments for patients
with recurrent, metastatic, or persistent cervical cancer. Most patients are young and survival …

Tumor-infiltrating T cells offer a promising avenue for cancer treatment, yet their states
remain to be fully characterized. Here we present a single-cell atlas of T cells from 308,048 …

Epidemiological data suggest a protective effect for estrogen replacement therapy on colon
cancer. The estrogen receptor (ER) is required for the action of estrogen. The ER-β isoform is …

Although controversial, recent studies suggest that serous ovarian carcinomas may arise
from fallopian tube fimbria rather than ovarian surface epithelium. We developed an in vitro …

Previous studies of oncogene and tumor suppressor gene alterations have suggested that
differences exist in the molecular pathogenesis of the various histological types of …

Cell-free circulating linear DNA is being explored for noninvasive diagnosis and management
of tumors and fetuses, the so-called liquid biopsy. Previously, we observed the presence …